By novel peptide engineering,
we guide the immune system
to recognize and eradicate tumors.
Immunotherapy is one of the most exciting breakthroughs in modern medicine. Unfortunately, so far only a minority of patients benefit from these advances. Our mission is to change this.
The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.
Watch
Anexo Pharma builds on over 15 years of cutting-edge research.
Contact us for any Q&A, Our experts are ready to assist.
By novel peptide engineering,
we guide the immune system
to recognize and eradicate tumors.
Immunotherapy is one of the most exciting breakthroughs in modern medicine. Unfortunately, so far only a minority of patients benefit from these advances. Our mission is to change this.
The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.
Anexo Pharma builds on over 15 years of cutting-edge research.
Contact us for any Q&A, Our experts are ready to assist.